Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine

Crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine

US Patent 11633400 · Granted Apr 25, 2023

Estimated economic value: $617,771,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isofagomine salts, methods of use and formulations2025
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters2025
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters2025
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters2025
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters2025
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters2025
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl es2025
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl es2025
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl es2025
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl es2025
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl es2025
Stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid2024